Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.

MLA

Drake, Justin M., et al. “Metastatic Castration-Resistant Prostate Cancer Reveals Intrapatient Similarity and Interpatient Heterogeneity of Therapeutic Kinase Targets.” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 49, Dec. 2013, pp. E4762–69. EBSCOhost, https://doi.org/10.1073/pnas.1319948110.

APA

Drake, J. M., Graham, N. A., Lee, J. K., Stoyanova, T., Faltermeier, C. M., Sud, S., Titz, B., Huang, J., Pienta, K. J., Graeber, T. G., & Witte, O. N. (2013). Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proceedings of the National Academy of Sciences of the United States of America, 110(49), E4762–E4769. https://doi.org/10.1073/pnas.1319948110

Chicago

Drake, Justin M, Nicholas A Graham, John K Lee, Tanya Stoyanova, Claire M Faltermeier, Sudha Sud, Björn Titz, et al. 2013. “Metastatic Castration-Resistant Prostate Cancer Reveals Intrapatient Similarity and Interpatient Heterogeneity of Therapeutic Kinase Targets.” Proceedings of the National Academy of Sciences of the United States of America 110 (49): E4762–69. doi:10.1073/pnas.1319948110.